Related Experiment Video
Updated: Dec 11, 2025

Detection of Helicobacter pylori Infection and Antibiotic Resistance via Stool Quantitative Polymerase Chain Reaction Analysis
Published on: May 16, 2025
Helicobacter pylori infection in children
Idalmis Aguilera Matos1, Sarah Esther Diaz Oliva1, Angel A Escobedo2
1Pediatric Gastroenterology, Institute of Gastroenterology, Havana, Cuba.
Helicobacter pylori infection is common globally, often asymptomatic in children. Treatment decisions for childhood H. pylori focus on specific benefits due to resistance and fewer complications.
Area of Science:
- Pediatric Infectious Diseases
- Gastroenterology
- Microbiology
Background:
- Helicobacter pylori infection is highly prevalent worldwide, typically acquired in childhood.
- Associated with severe gastroduodenal conditions like ulcers, atrophy, and cancers.
- High antimicrobial resistance complicates eradication efforts.
Purpose of the Study:
- To review current considerations for diagnosing and treating H. pylori infection in children.
- To emphasize outcomes and treatment strategies specific to pediatric cases.
- To discuss the challenges posed by antimicrobial resistance in H. pylori eradication.
Main Methods:
- This is a review article, synthesizing current knowledge on childhood H. pylori infection.
- Focuses on epidemiological data, diagnostic approaches, and treatment regimens.
- Examines outcomes and challenges in pediatric H. pylori management.
Main Results:
- Childhood H. pylori infections are often asymptomatic with fewer complications than in adults.
- Potential inverse relationships with allergic and inflammatory bowel diseases are under investigation.
- Diagnosis and treatment in children are reserved for specific circumstances with clear benefits.
Conclusions:
- The management of H. pylori in children requires careful consideration of risks, benefits, and antimicrobial resistance.
- Further research into H. pylori's role in pediatric health, including its relationship with other diseases, is warranted.
- Tailored treatment strategies are essential for effective H. pylori eradication in pediatric populations.
More Related Videos
03:47Retinal and Choroidal Thickness Changes in Populations with Helicobacter pylori Infection by Swept-Source Optical Coherence Tomography
Published on: November 1, 2024
05:23Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
Related Concept Videos
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.